Advanced search
Publication Cover
Neurological Research
A Journal of Progress in Neurosurgery, Neurology and Neurosciences
Volume 39, 2017 - Issue 5
Submit an article Journal homepage
268
Views
10
CrossRef citations to date
0
Altmetric
Rapid Communication

RAB7L1 promoter polymorphism and risk of Parkinson’s disease; a case-control study

Ali KhalighIranian Research Center of Healthy Aging, Sabzevar University of Medical Sciences, Sabzevar, Iran
,
Maryam GoudarzianIranian Research Center of Healthy Aging, Sabzevar University of Medical Sciences, Sabzevar, Iran
,
Alireza MoslemSabzevar University of Medical Sciences, Sabzevar, Iran
,
Amirhosein MehrtashMolecular Medicine Department, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran
,
Javad JamshidiNoncommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran
,
Hossein DarvishDepartment of Medical Genetics, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
&
Babak EmamalizadehFaculty of Medicine, Department of Medical Genetics, Tabriz University of Medical Sciences, Tabriz, IranCorrespondence[email protected]
 show all
Pages 468-471 | Received 02 Nov 2016, Accepted 16 Feb 2017, Published online: 28 Feb 2017

References

  • Jamshidi J, Movafagh A, Emamalizadeh B, et al. HLA-DRA is associated with Parkinson’s disease in Iranian population. Int J Immunogenet. 2014;41(6):508–511.10.1111/iji.2014.41.issue-6
  • MacLeod DA, Rhinn H, Kuwahara T, et al. RAB7L1 interacts with LRRK2 to modify intraneuronal protein sorting and parkinson’s disease risk. Neuron. 2013;77(3):425–439.10.1016/j.neuron.2012.11.033
  • Emamalizadeh B, Movafagh A, Akbari M, et al. RIT2, a susceptibility gene for Parkinson’s disease in Iranian population. Neurobiol Aging. 2014;35(12):e27–e28.10.1016/j.neurobiolaging.2014.07.013
  • Gao J, Xu H, Huang X, et al. Short communication: genetic variations of SLC2A9 in relation to Parkinson’s disease. Transl Neurodegener. 2013;2(1):5.
  • Wood-Kaczmar A, Gandhi S, Wood N. Understanding the molecular causes of Parkinson’s disease. Trends Mol Med. 2006;12(11):521–528.10.1016/j.molmed.2006.09.007
  • Gan-Or Z, Bar-Shira A, Dahary D, et al. Association of sequence alterations in the putative promoter of RAB7L1 with a reduced parkinson disease risk. Arch Neurol. 2012;69(1):105–110.10.1001/archneurol.2011.924
  • Shimizu F, Katagiri T, Suzuki M, et al. Cloning and chromosome assignment to 1q32 of a human cDNA (RAB7L1) encoding a small GTP-binding protein, a member of the RAS superfamily. Cytogenet Genome Res. 1997;77(3–4):261–263.10.1159/000134591
  • De Lau LM, Breteler MM. Epidemiology of Parkinson’s disease. Lancet Neurol. 2006;5(6):525–535.10.1016/S1474-4422(06)70471-9
  • Satake W, Nakabayashi Y, Mizuta I, et al. Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson’s disease. Nat Genet. 2009;41(12):1303–1307.10.1038/ng.485
  • Simón-Sánchez J, Schulte C, Bras JM, et al. Genome-wide association study reveals genetic risk underlying Parkinson’s disease. Nat Genet. 2009;41(12):1308–1312.10.1038/ng.487
  • Tan E-K, Kwok H-K, Tan L, et al. Analysis of GWAS-linked loci in Parkinson disease reaffirms PARK16 as a susceptibility locus. Neurology. 2010;75(6):508–512.10.1212/WNL.0b013e3181eccfcd
  • Tucci A, Nalls MA, Houlden H, et al. Genetic variability at the PARK16 locus. Eur J Hum Genet. 2010;18(12):1356–1359.10.1038/ejhg.2010.125
  • Xia H, Luo Q, Li XX, et al. Association between PARK16 gene polymorphisms and susceptibility of Parkinson’s disease in a Chinese population. Genet Mol Res. 2015;14(2):2978–2985.10.4238/2015.April.10.7
  • Mata IF, Yearout D, Alvarez V, et al. Replication of MAPT and SNCA, but not PARK16-18, as susceptibility genes for Parkinson’s disease. Mov Disord. 2011;26(5):819–823.10.1002/mds.v26.5
  • Consortium IPDG. Imputation of sequence variants for identification of genetic risks for Parkinson’s disease: a meta-analysis of genome-wide association studies. Lancet. 2011;377(9766):641–649.
  • Goudarzian M, Khaligh A, Fourozan R, et al. The rs1572931 polymorphism of the RAB7L1 gene promoter is associated with reduced risk of Parkinson’s disease. Neurol Res. 2015;37(11):1029–1031. PubMed PMID: 26344175.10.1179/1743132815Y.0000000085

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.